INO · Inovio Pharmaceuticals, Inc. · Congressional Trades
$1.17
+0.04 (+3.54%)
At close · Oct 7
View the 10-K filed Mar 12, 2026
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We do not currently have sufficient working capital to fund our planned operations for the next twelve months and substantial doubt exists as to our ability to continue as a going concern.”View the 10-Q filed Aug 12, 2026
Customer concentration
— key customers 100% of revenue
Key customers — 100% of revenue (the years ended December 31, 2025 and 2024)
“During the years ended December 31, 2025 and 2024, we derived 100% of our revenue from ApolloBio.”
Market Cap
$119.42M
Shares
103.40M
Volume · Oct 7
2.8M
Avg daily vol (3M)
3.77M
Transactions in this listed security by members of the U.S. Congress, disclosed under the STOCK Act. Lawmakers must report trades within 45 days, so the filing date can lag the trade itself.
| Date | Member | Position | Type | Owner | Amount | Filed | Lag |
|---|---|---|---|---|---|---|---|
| 2020-09-08 | Christopher L. Jacobs | Representative | Sell ST · Inovio Pharmaceuticals, Inc. (INO) | — CL TRUST > LDJ FAM INV LLC > Parametric | $1K - $15K | 2020-11-06 | 59d late |
Showing 1–1 of 1 trades